SHREE GANESH REMEDIES
|
SHREE GANESH REMEDIES Last 5 Year Financial Ratios History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 13.83 | 17.97 | 21.89 | 11.67 | 6.95 |
| CEPS(Rs) | 21.99 | 25.42 | 26.64 | 10.56 | 6.01 |
| DPS(Rs) | - | - | - | 1.50 | 1.25 |
| Book NAV/Share(Rs) | 126.95 | 113.07 | 95.07 | 47.04 | 37.70 |
| Tax Rate(%) | 26.05 | 26.22 | 26.34 | 22.95 | 28.05 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 31.67 | 35.21 | 32.32 | 19.55 | 24.76 |
| EBIT Margin(%) | 24.94 | 29.97 | 29.97 | 22.08 | 25.12 |
| Pre Tax Margin(%) | 21.72 | 28.07 | 29.50 | 21.23 | 24.54 |
| PAT Margin (%) | 16.06 | 20.71 | 21.73 | 16.36 | 17.66 |
| Cash Profit Margin (%) | 25.53 | 29.30 | 26.46 | 19.94 | 20.60 |
| Performance Ratios | |||||
| ROA(%) | 8.61 | 12.20 | 24.08 | 21.67 | 15.08 |
| ROE(%) | 11.53 | 17.26 | 34.22 | 27.55 | 18.43 |
| ROCE(%) | 14.63 | 19.53 | 37.81 | 34.79 | 25.66 |
| Asset Turnover(x) | 0.54 | 0.59 | 1.11 | 1.33 | 0.85 |
| Sales/Fixed Asset(x) | 0.80 | 0.95 | 1.93 | 2.57 | 1.68 |
| Working Capital/Sales(x) | 1.72 | 1.81 | 2.51 | 2.73 | 1.86 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.25 | 1.05 | 0.52 | 0.39 | 0.60 |
| Receivable days | 90.51 | 69.81 | 53.79 | 78.42 | 100.48 |
| Inventory Days | 75.97 | 77.02 | 44.31 | 36.84 | 67.29 |
| Payable days | 67.15 | 72.01 | 40.38 | 40.52 | 76.90 |
| Valuation Parameters | |||||
| PER(x) | 30.36 | 39.58 | 30.49 | 4.61 | 5.78 |
| PCE(x) | 19.10 | 27.98 | 25.05 | 5.10 | 6.68 |
| Price/Book(x) | 3.31 | 6.29 | 7.02 | 1.54 | 1.44 |
| Yield(%) | - | - | - | 2.07 | 2.31 |
| EV/Net Sales(x) | 5.09 | 8.67 | 6.97 | 1.05 | 1.37 |
| EV/Core EBITDA(x) | 14.62 | 21.92 | 19.54 | 4.09 | 4.88 |
| EV/EBIT(x) | 20.18 | 28.20 | 22.62 | 4.75 | 5.45 |
| EV/CE(x) | 2.87 | 5.13 | 5.54 | 1.22 | 1.17 |
| M Cap / Sales | 4.93 | 8.41 | 6.81 | 1.02 | 1.38 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 0.63 | -13.74 | 96.65 | 81.28 | - |
| Core EBITDA Growth(%) | -11.39 | -4.31 | 173.19 | 65.79 | - |
| EBIT Growth(%) | -17.37 | -13.91 | 174.32 | 59.32 | - |
| PAT Growth(%) | -23.01 | -17.93 | 168.45 | 67.93 | - |
| EPS Growth(%) | -23.01 | -17.89 | 87.52 | 67.93 | - |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.19 | 0.26 | 0.30 | 0.11 | 0.02 |
| Current Ratio(x) | 3.40 | 3.53 | 2.98 | 3.26 | 3.80 |
| Quick Ratio(x) | 2.50 | 2.63 | 2.02 | 2.64 | 2.84 |
| Interest Cover(x) | 7.74 | 15.84 | 63.85 | 26.05 | 43.45 |
| Total Debt/Mcap(x) | 0.06 | 0.04 | 0.04 | 0.07 | 0.02 |
Compare Financial Ratios of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹875.5 Cr | 31.9% | 9.9% | 16.3% | Stock Analytics | |
| No other companies found in this Industry | ||||||
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | 31.9% |
9.9% |
16.3% |
| SENSEX | -1.2% |
-2.6% |
-5.2% |
You may also like the below Video Courses
